SLC35B2

Summary

Gene Symbol: SLC35B2
Description: solute carrier family 35 member B2
Alias: PAPST1, SLL, UGTrel4, adenosine 3'-phospho 5'-phosphosulfate transporter 1, 3'-phosphoadenosine 5'-phosphosulfate transporter, PAPS transporter 1, solute carrier family 35 (adenosine 3'-phospho 5'-phosphosulfate transporter), member B2, solute carrier family 35 member B2 variant 2
Species: human
Products:     SLC35B2

Top Publications

  1. Chen D, Shen D, Yang S, Fang X. Clinicopathological features of splenic tumours of lymphoid tissue. Pathol Res Pract. 2018;214:1952-1958 pubmed publisher
    ..3%,1/43) in turn, and the remaining 10 cases were chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) (n = 4), hairy cell leukaemia (HCL) (n = 1), hepatosplenic T-cell lymphoma (HSTL) (n = 5)...
  2. Aschebrook Kilfoy B, Zheng T, Foss F, Ma S, Han X, Lan Q, et al. Polymorphisms in immune function genes and non-Hodgkin lymphoma survival. J Cancer Surviv. 2012;6:102-14 pubmed publisher
    ..found that risk of death, relapse, and secondary cancers varied by specific SNPs for the follicular, DLBCL, and CLL/SLL histologic types...
  3. Amoori N, Cheraghi M, Fallahzadeh H, Rahmani H. Lack of association between using aspirin and development of non-Hodgkins lymphoma: a meta-analysis. Asian Pac J Cancer Prev. 2015;16:787-92 pubmed
    ..01 (95%CI: 0.82-1.26, p=0.86). The odds ratio (OR) of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) was 0.85 (95%CI: 0.75-0.97, p=0...
  4. Howlader N, Morton L, Feuer E, Besson C, Engels E. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends. Cancer Epidemiol Biomarkers Prev. 2016;25:174-9 pubmed publisher
    ..7% for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), and -5.3% for follicular lymphoma. Incidence rates for these subtypes did not decrease until after 2003...
  5. Clarke C, Glaser S, Gomez S, Wang S, Keegan T, Yang J, et al. Lymphoid malignancies in U.S. Asians: incidence rate differences by birthplace and acculturation. Cancer Epidemiol Biomarkers Prev. 2011;20:1064-77 pubmed publisher
    ..than white populations, only follicular lymphoma (FL), chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), and nodular sclerosis (NS) HL rates were statistically significantly lower among foreign-born than U.S...
  6. Machiela M, Lan Q, Slager S, Vermeulen R, Teras L, Camp N, et al. Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes. Hum Mol Genet. 2016;25:1663-76 pubmed publisher
    ..Subtype-specific analyses indicated that chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) was the principal NHL subtype contributing to this association (OR = 2.60, 95% CI 1.93-3.51,P-value = 4...
  7. Teras L, Rollison D, Pawlita M, Michel A, Blase J, Willhauck Fleckenstein M, et al. Prediagnostic circulating polyomavirus antibody levels and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2015;24:477-80 pubmed publisher
    ..For NHL subtypes, TSV antibody level above the median was associated with a lower risk of CLL/SLL; however, this association was based on 19 cases in the high antibody group and may be due to chance...
  8. Kuncman Ł, Danielska J, Kuncman W, Gottwald L, Moszyńska Zielińska M, Fijuth J. [Synchronous occurrence of four malignancies in a 55-year-old woman with uterine cervical cancer. Case report and review of literature]. Ginekol Pol. 2016;87:314-7 pubmed publisher
    ..four malignancies: cervical cancer, breast cancer, chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and an olfactory groove meningioma...
  9. Xydis V, Zikou A, Kostadima V, Astrakas L, Kosta P, Argyropoulou M. The association between multiple sclerosis and spondylosis: When and why. Eur J Radiol. 2017;91:47-51 pubmed publisher
    ..indices (disk dehydration, disk protrusion, abnormal posture and osteophytosis) and the spinal cord lesion load (SLL) was evaluated...

More Information

Publications119 found, 100 shown here

  1. He H, Cheng L, Weiss L, Chu P. Clinical outcome of incidental pelvic node malignant B-cell lymphomas discovered at the time of radical prostatectomy. Leuk Lymphoma. 2007;48:1976-80 pubmed
    ..Of 13 cases, 9 were chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), 3 marginal zone B-cell lymphoma (MZL) and 1 mantle cell lymphoma (MCL)...
  2. Wu Y, Cao X, Cai H, Zhang L, Zhou D, Li J. [Clinical features and prognosis of 17 patients with primary cold agglutinin disease]. Zhonghua Xue Ye Xue Za Zhi. 2017;38:789-793 pubmed publisher
    ..macroglobulinemia/lymphoplasmacytic lymphoma (WM/LPL) , 2 small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL) , and 2 splenic marginal zone lymphoma (SMZL) . 15 patients experienced anemia...
  3. Briscoe D, Safieh C, Ton Y, Shapiro H, Assia E, Kidron D. Characteristics of orbital lymphoma: a clinicopathological study of 26 cases. Int Ophthalmol. 2018;38:271-277 pubmed publisher
    ..One small cell lymphomas was of follicular type on a background of CLL, and the other was CLL/SLL type. Fourteen cases were primary orbital disease, and 12 cases were systemic disease...
  4. Tram Do B, Charpentier A, Bourré Tessier J, Maietta A, Doucet S, Ayad T, et al. Unusual presentation for small lymphocytic lymphoma: Case report of a man with bilateral ear involvement and review of the literature. Eur Ann Otorhinolaryngol Head Neck Dis. 2019;: pubmed publisher
    ..Biopsy of the right ear revealed a B-cell small lymphocytic lymphoma (SLL). The patient responded to radiotherapy well...
  5. Scarfo L, Ferreri A, Ghia P. Chronic lymphocytic leukaemia. Crit Rev Oncol Hematol. 2016;104:169-82 pubmed publisher
    ..CLL (and the corresponding nodal entity small lymphocytic lymphoma, SLL) is classified as a lymphoproliferative disorder characterised by the relentless accumulation of mature B-..
  6. Snorek M, Bulava A, Vonke I. Chronic lymphocytic leukemia skin infiltration mimicking an ICD pocket infection: a case report. BMC Cardiovasc Disord. 2017;17:89 pubmed publisher
    ..skin infiltration by CD-5 positive low-grade B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL)...
  7. Wang S, Carrington M, Berndt S, Slager S, Bracci P, Voutsinas J, et al. HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes. Cancer Res. 2018;78:4086-4096 pubmed publisher
    ..DLBCL), 2,686 follicular lymphomas (FL), 2,878 chronic lymphocytic leukemia/small lymphocytic lymphomas (CLL/SLL), 741 marginal zone lymphomas (MZL), and 8,753 controls of European descent...
  8. Nwanze J, Siddiqui M, Stevens K, Saxe D, Cohen C. MYC Immunohistochemistry Predicts MYC Rearrangements by FISH. Front Oncol. 2017;7:209 pubmed publisher
    ..between DLBCL and BL; 5 B-cell lymphoma not otherwise specified; 1 EBV-related B-cell lymphoma; 1 composite CLL/SLL-large cell lymphoma; and 6 designated as high-grade or aggressive B-cell lymphoma...
  9. Brown N, Betz B, Weigelin H, Elenitoba Johnson K, Lim M, Bailey N. Evaluation of allele-specific PCR and immunohistochemistry for the detection of BRAF V600E mutations in hairy cell leukemia. Am J Clin Pathol. 2015;143:89-99 pubmed publisher
    ..An additional 11 SMZLs, 100 FLs, 20 MCLs, 83 CLL/SLL specimens, and 49 reactive tonsils within tissue microarrays were stained with VE1...
  10. Park R, Wang T, Koundakjian D, Hultquist J, Lamothe Molina P, Monel B, et al. A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors. Nat Genet. 2017;49:193-203 pubmed publisher
    ..Tyrosylprotein sulfotransferase 2 (TPST2) and solute carrier family 35 member B2 (SLC35B2) function in a common pathway to sulfate CCR5 on extracellular tyrosine residues, facilitating CCR5 recognition ..
  11. Rai S, Tanaka H, Fujimoto K, Kumode T, Inoue H, Taniguchi Y, et al. Classic Hodgkin Lymphoproliferative Diseases Clonally Unrelated to B-Chronic Lymphocytic Leukemia Successfully Treated with Bendamustine Plus Rituximab. Cancers (Basel). 2018;10: pubmed publisher
    ..of de novo lymphocyte-rich classic Hodgkin lymphoproliferative diseases (LPDs) with small lymphocytic lymphoma (SLL)...
  12. Finnes H, Chaffee K, Call T, Ding W, Kenderian S, Bowen D, et al. Pharmacovigilance during ibrutinib therapy for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in routine clinical practice. Leuk Lymphoma. 2017;58:1376-1383 pubmed publisher
    ..Formal medication review by a pharmacist should be considered in all patients initiating ibrutinib. ..
  13. Mercado Reyes J, Almanza A, Segura Chama P, Pellicer F, Mercado F. D2-like receptor agonist synergizes the μ-opioid agonist spinal antinociception in nociceptive, inflammatory and neuropathic models of pain in the rat. Eur J Pharmacol. 2019;853:56-64 pubmed publisher
    ..Intraplantar injection of complete Freund's adjuvant (CFA) and sciatic loose ligation (SLL) were used for inflammatory and neuropathic models of pain, respectively...
  14. Keating G. Idelalisib: a review of its use in chronic lymphocytic leukaemia and indolent non-Hodgkin's lymphoma. Target Oncol. 2015;10:141-51 pubmed publisher
    ..leukaemia (CLL), relapsed follicular B-cell non-Hodgkin's lymphoma (NHL) and relapsed small lymphocytic lymphoma (SLL) in the USA and for the treatment of CLL and refractory follicular lymphoma in the EU...
  15. Chen Y, Yu K, Shao W, Tseng C, Pan W. Novel Mold-Resistant Building Materials Impregnated with Thermally Reduced Nano-Silver. Indoor Air. 2017;: pubmed publisher
    ..demonstrated excellent antifungal efficiency: mold growth was almost completely inhibited for 28 days at the low SLL of 0.5 ?g/cm2 ...
  16. Sachanas S, Pangalis G, Moschogiannis M, Yiakoumis X, Koulieris E, Tsirkinidis P, et al. Hodgkin Lymphoma Transformation of Chronic Lymphocytic Leukemia Under Ibrutinib Therapy: Chance Association or Therapy-related?. Anticancer Res. 2017;37:3277-3280 pubmed
    The established treatment algorithms for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) are currently challenged by novel classes of drugs, with ibrutinib being one of the most effective...
  17. Oueslati I, Manaï H, Madrigal Martínez M, Martínez Cañas M, Sánchez Casas J, Zarrouk M, et al. Volatile molecular markers of VOO Thermo-oxidation: Effect of heating processes, macronutrients composition, and olive ripeness on the new emitted aldehydic compounds. Food Res Int. 2018;106:654-665 pubmed publisher
    ..During thermo-oxidation, the ECN44 (LLO, and OLnO), and the ECN46 (OLO, and PLO + SLL) compounds decreased, whereas, the ECN48 (OOO, and PPO), and the ECN50 (SOO) compounds ..
  18. Li Y, Zhang Z, Zhao F. [Value of Multiparameter Flow Cytometry in Diagnosis of Non-Hodgkin's Lymphoma]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016;24:102-5 pubmed publisher
    ..After FCM immune typing and cytological smear, 6 cases was confirmed to be B-SLL, 1 case was B-NHL, 1 case was FL, 5 cases was DLBCL, 2 cases was T-NHL, 3 cases was T-LBL, 1 case was NK/T-NHL, 1 ..
  19. Gao H, Lin Y, He J, Zhou S, Liang M, Huang C, et al. Role of heparan sulfate in the Zika virus entry, replication, and cell death. Virology. 2019;529:91-100 pubmed publisher
    ..Our study generated several HS biosynthesis-deficient cell clones by disrupting SLC35B2, B3GAT3, or B4GALT7 gene using the CRISPR/Cas9 system...
  20. Pongas G, Cheson B. PI3K signaling pathway in normal B cells and indolent B-cell malignancies. Semin Oncol. 2016;43:647-654 pubmed publisher
    ..would be considered appropriate and as a single agent for patients with relapsed small lymphocytic lymphoma (SLL) and relapsed follicular lymphoma (FL)...
  21. Agbay R, Jain N, Loghavi S, Medeiros L, Khoury J. Histologic transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma. Am J Hematol. 2016;91:1036-43 pubmed publisher
    Although generally considered a clinically indolent neoplasm, CLL/SLL may undergo transformation to a clinically aggressive lymphoma. The most common form of transformation, to DLBCL, is also known as Richter syndrome...
  22. Markham A. Idelalisib: first global approval. Drugs. 2014;74:1701-7 pubmed publisher
    ..leukaemia(CLL), relapsed follicular B-cell non-Hodgkin lymphoma(NHL) and relapsed small lymphocytic lymphoma (SLL) [corrected]...
  23. Blair H. Duvelisib: First Global Approval. Drugs. 2018;78:1847-1853 pubmed publisher
    ..of adult patients with relapsed or refractory chronic lymphocytic leukaemia (CLL)/small lymphocytic lymphoma (SLL) after at least two prior therapies...
  24. Zirlik K, Veelken H. Idelalisib. Recent Results Cancer Res. 2018;212:243-264 pubmed publisher
    ..in relapsed/refractory chronic lymphocytic leukemia (CLL), follicular lymphoma (FL), and small lymphocytic lymphoma (SLL). This review presents the preclinical and clinical activity of idelalisib with a focus on clinical studies in CLL.
  25. Ujjani C, Ramzi P, Gehan E, Wang H, Wang Y, Cheson B. Ofatumumab and bendamustine in previously treated chronic lymphocytic leukemia and small lymphocytic lymphoma. Leuk Lymphoma. 2015;56:915-20 pubmed publisher
    ..Given excellent data with bendamustine and rituximab in relapsed/refractory CLL/small lymphocytic lymphoma (SLL), this phase II study evaluated the combination of ofatumumab and bendamustine in previously treated patients...
  26. Maneiro Catoira R, Brégains J, García Naya J, Castedo L. Time Modulated Arrays: From their Origin to Their Utilization in Wireless Communication Systems. Sensors (Basel). 2017;17: pubmed publisher
    ..The technique can be used for improving the side-lobe level (SLL) topology of the radiation pattern at the central frequency and/or to profitably exploit the harmonic patterns in ..
  27. Konopka G, Chim H. Optimal management of scapholunate ligament injuries. Orthop Res Rev. 2018;10:41-54 pubmed publisher
    Scapholunate ligament (SLL) injuries are a common cause of wrist pain and instability. Treatment of SLL injuries requires intricate understanding of wrist anatomy and biomechanics...
  28. Svenningsen M, Herborg L, Hokland P, Ludvigsen M. Monoclonal B-cell lymphocytosis; not the same as B-cell chronic lymphocytic leukaemia. Dan Med J. 2017;64: pubmed
    ..benign monoclonal B-cell lymphocytosis (MBL), chronic ?lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL)...
  29. Jelloul F, Chen Q, Yang T, Haghi N, Brody J, Zhang X, et al. Composite Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia and Follicular Lymphoma: A Clinicopathological Study of Six Cases. Int J Surg Pathol. 2017;:1066896917737161 pubmed publisher
    Composite small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL) and follicular lymphoma (FL) is extremely rare, and only 13 cases have been reported previously.
  30. Lei J, Yang J, Chen X, Zhang Z, Fu G, Hao Y. Experimental demonstration of conformal phased array antenna via transformation optics. Sci Rep. 2018;8:3807 pubmed publisher
    ..the same radiation characteristics of a planar array with wide-angle beam-scanning and low side lobe level (SLL)...
  31. Miscusi M, Ramieri A, Forcato S, Giuffrè M, Trungu S, Cimatti M, et al. Comparison of pure lateral and oblique lateral inter-body fusion for treatment of lumbar degenerative disk disease: a multicentric cohort study. Eur Spine J. 2018;27:222-228 pubmed publisher
    ..The mean correction was 6.25° for cCobb (11.3° in LIF and 1.9° in OLIF), 2.5° for sLL (2° in LLIF and 4° in OLIF)...
  32. Wang R, Wang B, Hu C, Ding X. Wide-angle scanning planar array with quasi-hemispherical-pattern elements. Sci Rep. 2017;7:2729 pubmed publisher
    ..from less than -77° to more than +77° with a gain fluctuation less than 5 dB and a maximum side lobe level (SLL) less than -10 dB...
  33. Shanei M, Hashemi M, Fathi D, Zapata Rodríguez C. Dielectric metalenses with engineered point spread function. Appl Opt. 2017;56:8917-8923 pubmed publisher
    ..42?eff) and apodization with nearly faded SLLs are achievable. Our approach introduced in this paper provides a new way to design high efficiency metalenses with desired FWHM and SLL of focal spot.
  34. Tatarano S, Enokida H, Yamada Y, Nishimura H, Nakagawa M. Living Kidney Donor With Small Lymphocytic Lymphoma at the Time of Donation: A Case Report. Transplant Proc. 2018;50:2581-2582 pubmed publisher
    ..screening for malignancies was performed, we experienced a case of living donor with small lymphocytic lymphoma (SLL) at the time of donation. A 53-year-old woman was referred to our hospital for a kidney donation to her son...
  35. Wiweger M, Avramut C, de Andrea C, Prins F, Koster A, Ravelli R, et al. Cartilage ultrastructure in proteoglycan-deficient zebrafish mutants brings to light new candidate genes for human skeletal disorders. J Pathol. 2011;223:531-42 pubmed publisher
    ..synthesis: dackel (dak/ext2), lacking heparan sulphate; hi307 (?3gat3), deficient for most GAGs; pinscher (pic/slc35b2), presenting defective sulphation of GAGs and other molecules; hi954 (uxs1), lacking Notch and most GAGs due to ..
  36. Tan Y, Merchant J, Sharma V, Davies B, Singh S, Stewart R, et al. Extensive Necrotising Enterocolitis: Objective Evaluation of the Role of Second-Look Laparotomy in Bowel Salvage and Survival. World J Surg. 2015;39:3016-22 pubmed publisher
    We investigated the role and outcome of a planned second-look laparotomy (SLL) in preserving bowel in extensive necrotizing enterocolitis (NEC)...
  37. Ashykhmina N, Lorenz M, Frerigmann H, Koprivova A, Hofsetz E, Stührwohldt N, et al. PAPST2 Plays Critical Roles in Removing the Stress Signaling Molecule 3'-Phosphoadenosine 5'-Phosphate from the Cytosol and Its Subsequent Degradation in Plastids and Mitochondria. Plant Cell. 2019;31:231-249 pubmed publisher
    ..The plastidial transporter PAPST1 (PAPS TRANSPORTER1) delivers newly synthesized PAPS from the stroma to the cytosol...
  38. Miller B, Przepiorka D, De Claro R, Lee K, Nie L, Simpson N, et al. FDA approval: idelalisib monotherapy for the treatment of patients with follicular lymphoma and small lymphocytic lymphoma. Clin Cancer Res. 2015;21:1525-9 pubmed publisher
    ..treatment of patients with relapsed follicular B-cell non-Hodgkin lymphoma or relapsed small lymphocytic lymphoma (SLL) who have received at least two prior systemic therapies...
  39. Gardner A, van Eps A, Watts M, Burns T, Belknap J. A novel model to assess lamellar signaling relevant to preferential weight bearing in the horse. Vet J. 2017;221:62-67 pubmed publisher
    Supporting limb laminitis (SLL) is a devastating sequela to severe unilateral lameness in equine patients. The manifestation of SLL, which usually only affects one limb, is unpredictable and the etiology is unknown...
  40. Fraser G, Cramer P, Demirkan F, Silva R, Grosicki S, Pristupa A, et al. Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma. Leukemia. 2019;33:969-980 pubmed publisher
    ..and rituximab (BR) for previously treated chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) without deletion 17p...
  41. Nasr S, Shanafelt T, Hanson C, Fidler M, Cornell L, Sethi S, et al. Granulomatous interstitial nephritis secondary to chronic lymphocytic leukemia/small lymphocytic lymphoma. Ann Diagn Pathol. 2015;19:130-6 pubmed publisher
    ..we report a series of 5 patients with GIN secondary to chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)...
  42. Coffey G, Feng J, Betz A, Pandey A, Birrell M, Leeds J, et al. Cerdulatinib Pharmacodynamics and Relationships to Tumor Response Following Oral Dosing in Patients with Relapsed/Refractory B-cell Malignancies. Clin Cancer Res. 2019;25:1174-1184 pubmed publisher
    ..The study enrolled 8 patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), 13 with follicular lymphoma, 16 with diffuse large B-cell lymphoma (DLBCL), and 6 with mantle cell lymphoma...
  43. Slager S, Benavente Y, Blair A, Vermeulen R, Cerhan J, Costantini A, et al. Medical history, lifestyle, family history, and occupational risk factors for chronic lymphocytic leukemia/small lymphocytic lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr. 2014;2014:41-51 pubmed publisher
    Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are two subtypes of non-Hodgkin lymphoma. A number of studies have evaluated associations between risk factors and CLL/SLL risk...
  44. Shao H, Xi L, Raffeld M, Feldman A, Ketterling R, Knudson R, et al. Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases. Mod Pathol. 2011;24:1421-32 pubmed publisher
    ..molecular and cytogenetic analysis of seven cases of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) associated with histiocytic and dendritic cell sarcomas...
  45. Chang J, Harrington A, Olteanu H, Vantuinen P, Kroft S. Proliferation centers in bone marrows involved by chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic analysis. Ann Diagn Pathol. 2016;25:15-19 pubmed publisher
    ..centers (PCs) are a characteristic finding in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) lymph nodes, and their presence and extent in this site are not currently felt to be related to clinical course...
  46. Wasik A, Priebe V, Lord M, Jeppsson Ahlberg Å, Christensson B, Sander B. Flow cytometric analysis of SOX11: a new diagnostic method for distinguishing B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma from mantle cell lymphoma. Leuk Lymphoma. 2015;56:1425-31 pubmed publisher
    ..between mantle cell lymphoma (MCL) and B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL) is essential, since MCL usually has a more aggressive clinical course...
  47. Blanca J, Montero Pau J, Sauvage C, Bauchet G, Illa E, Díez M, et al. Genomic variation in tomato, from wild ancestors to contemporary breeding accessions. BMC Genomics. 2015;16:257 pubmed publisher
    ..lycopersicum (SLL), S. lycopersicum var. cerasiforme (SLC), and S. pimpinellifolium (SP) that were genotyped using 7,720 SNPs...
  48. Xavier E, Cornillon J, Ruggeri A, Chevallier P, Cornelissen J, Andersen N, et al. Outcomes of Cord Blood Transplantation Using Reduced-Intensity Conditioning for Chronic Lymphocytic Leukemia: A Study on Behalf of Eurocord and Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, Chronic Malignancies Working Par. Biol Blood Marrow Transplant. 2015;21:1515-23 pubmed publisher
    ..umbilical cord blood transplantation (UCBT) for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) are unknown...
  49. Puła B, Budziszewska B, Rybka J, Gil L, Subocz E, Długosz Danecka M, et al. Comparable Efficacy of Idelalisib Plus Rituximab and Ibrutinib in Relapsed/refractory Chronic Lymphocytic Leukemia: A Retrospective Case Matched Study of the Polish Adult Leukemia Group (PALG). Anticancer Res. 2018;38:3025-3030 pubmed
    ..BCRi) newly approved for relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (r/r CLL/SLL) treatment...
  50. Jofre Bonet M, Kamara J. Willingness to pay for health insurance in the informal sector of Sierra Leone. PLoS ONE. 2018;13:e0189915 pubmed publisher
    ..The results indicate that the average WTP for the HI is 20,237.16 SLL (3.6 USD) per adult but it ranges from about 14,000 SLL (2.5 USD) to about 35,000 SLL (6...
  51. Sivaraman J, Uma G, Venkatesan S, Umapathy M, Dhandapani V. Normal limits of ECG measurements related to atrial activity using a modified limb lead system. Anatol J Cardiol. 2015;15:2-6 pubmed publisher
    ..The mean P wave amplitude was 111±17μV in MLL I and 64±16μV in standard limb lead (SLL) I (p<0.001). Similarly it was 118±22μV in MLL II and 100±27μV in SLL II...
  52. Garces S, Khoury J, Kanagal Shamanna R, Salem A, Wang S, Ok C, et al. Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype, and TP53 disruption. Hum Pathol. 2018;82:215-231 pubmed publisher
    ..3 months versus undefined; P = .0241). These data suggest that identification of PCs in BM samples involved by CLL is associated with adverse prognostic features. ..
  53. JAYARAMAN S, Gandhi U, Sangareddi V, Mangalanathan U, Shanmugam R. Unmasking of atrial repolarization waves using a simple modified limb lead system. Anatol J Cardiol. 2015;15:605-10 pubmed publisher
    ..Standard limb lead (SLL) ECGs and MLL ECGs were recorded for 60 seconds each with an EDAN SE-1010 PC ECG system...
  54. Kane E, Skibola C, Bracci P, Cerhan J, Costas L, Smedby K, et al. Non-Hodgkin Lymphoma, Body Mass Index, and Cytokine Polymorphisms: A Pooled Analysis from the InterLymph Consortium. Cancer Epidemiol Biomarkers Prev. 2015;24:1061-70 pubmed publisher
    ..B-cell lymphoma (DLBCL), follicular lymphoma (FL), and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), joint associations of body mass index (from self-reported height and weight) and 12 polymorphisms in cytokines ..
  55. Deeks E. Ibrutinib: A Review in Chronic Lymphocytic Leukaemia. Drugs. 2017;77:225-236 pubmed publisher
    ..of certain haematological malignancies, including chronic lymphocytic leukaemia (CLL)/small lymphocytic lymphoma (SLL), which are the focus of this review...
  56. Juza R, Haluck R, Pauli E, Rogers A, Won E, LynSue J. Gastric sleeve leak: a single institution's experience with early combined laparoendoscopic management. Surg Obes Relat Dis. 2015;11:60-4 pubmed publisher
    ..However, staple line leak (SLL) remains a significant complication of this procedure with reported incidence ranging from 1%-7%...
  57. Cheng J, Cohen P. Lymphomatoid papulosis in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma: case report and literature review. Dermatol Online J. 2018;24: pubmed
    ..Small lymphocytic lymphoma (SLL) occurs when CLL cells infiltrate lymph nodes and other tissues but spare peripheral blood and bone marrow...
  58. Li Z, Liu J, Min W, Zhang D, Yang X, Sun Y. Effect of second-look laparoscopy on subsequent fertility outcome after laparoscopic salpingostomy for tubal pregnancy: a randomized controlled study. J Minim Invasive Gynecol. 2015;22:612-8 pubmed publisher
    To clarify the potential value of second-look laparoscopy (SLL) in improving fertility outcomes after laparoscopic salpingostomy for tubal pregnancy. Randomized controlled trial. West China Second University Hospital, Sichuan University...
  59. Schinasi L, De Roos A, Ray R, Edlefsen K, Parks C, Howard B, et al. Insecticide exposure and farm history in relation to risk of lymphomas and leukemias in the Women's Health Initiative observational study cohort. Ann Epidemiol. 2015;25:803-10 pubmed publisher
    ..Relationships with non-Hodgkin lymphoma (NHL), chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, plasma cell neoplasms, and myeloid leukemia were ..
  60. Parry H, Stevens T, Oldreive C, Zadran B, McSkeane T, Rudzki Z, et al. NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphoma. Oncotarget. 2016;7:68513-68526 pubmed publisher
    Chronic lymphocytic leukemia (B-CLL) and small lymphocytic lymphoma (SLL) are part of the same disease classification but are defined by differential distribution of tumor cells...
  61. Wuertinger C, Annes R, Hitzl W, Siepe C. Motion preservation following total lumbar disc replacement at the lumbosacral junction: a prospective long-term clinical and radiographic investigation. Spine J. 2018;18:72-80 pubmed publisher
    ..rating), range of motion (ROM) at the index- and cranially adjacent level as well as segmental lumbar lordosis (SLL) and global lumbar lordosis (GLL) were the outcome measures...
  62. Smith D, Goldstein L, Cheng M, James D, Kunkel L, Fardis M, et al. Modeling absolute lymphocyte counts after treatment of chronic lymphocytic leukemia with ibrutinib. Ann Hematol. 2015;94:249-56 pubmed publisher
    ..The PCYC-1102-CA study was a five-arm phase Ib/II open-label, nonrandomized, multicenter study in CLL/SLL. The arms and accruals were 420 and 840 mg/day treatment-naive elderly CLL/SLL (N = 27 and Nâ€..
  63. Woroniecka R, Rymkiewicz G, Grygalewicz B, Błachnio K, Rygier J, Jarmuż Szymczak M, et al. Cytogenetic and flow cytometry evaluation of Richter syndrome reveals MYC, CDKN2A, IGH alterations with loss of CD52, CD62L and increase of CD71 antigen expression as the most frequent recurrent abnormalities. Am J Clin Pathol. 2015;143:25-35 pubmed publisher
    Richter syndrome (RS) is a transformation of chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) into high-grade lymphoma. There are only limited data on flow cytometry (FCM) and cytogenetics in RS...
  64. Tandon B, Swerdlow S, Hasserjian R, Surti U, Gibson S. Chronic lymphocytic leukemia/small lymphocytic lymphoma: another neoplasm related to the B-cell follicle?. Leuk Lymphoma. 2015;56:3378-86 pubmed publisher
    ..paid to the critical nature of nodal involvement in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), the B-cell compartment it is most closely related to and its relationship to the follicle remain uncertain...
  65. Kunati S, Yang S, William B, Xu Y. An LC-MS/MS method for simultaneous determination of curcumin, curcumin glucuronide and curcumin sulfate in a phase II clinical trial. J Pharm Biomed Anal. 2018;156:189-198 pubmed publisher
    ..combination in patients with early-stage chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)...
  66. Sun H, Wang Y, Yuan C, Kong L, Xu X, Wang Y, et al. 7β-Methyl substituent is a structural locus associated with activity cliff for nepenthone analogues. Bioorg Med Chem. 2018;26:4254-4263 pubmed publisher
    ..as potential antidepressants from nepenthone analogues, starting from N-nor-N-cyclopropylmethyl-nepenthone (SLL-020ACP), a highly selective and potent KOR agonist, a series of 7β-methyl-nepenthone analogues was conceived, ..
  67. Kim C, Bassig B, Seow W, Hu W, Purdue M, Huang W, et al. Mitochondrial DNA copy number and chronic lymphocytic leukemia/small lymphocytic lymphoma risk in two prospective studies. Cancer Epidemiol Biomarkers Prev. 2015;24:148-53 pubmed publisher
    ..with non-Hodgkin lymphoma (NHL) risk, particularly chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)...
  68. Wu J, Zhang Y, Sun L, Zhai Q. Cyclin D1 expression by histiocytes may mimic cyclin D1-positive proliferation centres of chronic lymphocytic leukaemia/small lymphocytic lymphoma. Pathol Res Pract. 2018;214:72-75 pubmed publisher
    Cyclin D1, generally considered to be absent in chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL), has been reported in the proliferation centres (PCs) of recent CLL/SLL cases...
  69. Chim Ong A, Thawornkuno C, Chavalitshewinkoon Petmitr P, Punyarit P, Petmitr S. SLC35B2 expression is associated with a poor prognosis of invasive ductal breast carcinoma. Asian Pac J Cancer Prev. 2014;15:6065-70 pubmed
    ..The mRNA expression of novel B4GALT4, SLC35B2, and WDHD1 genes in breast cancer were examined in invasive ductal breast carcinoma (IDC) patients using ..
  70. Kita A, Jimbo M, Sakai R, Morimoto Y, Miki K. Crystal structure of a symbiosis-related lectin from octocoral. Glycobiology. 2015;25:1016-23 pubmed publisher
    D-Galactose-binding lectin from the octocoral, Sinularia lochmodes (SLL-2), distributes densely on the cell surface of microalgae, Symbiodinium sp...
  71. Roberts A, Davids M, Pagel J, Kahl B, Puvvada S, Gerecitano J, et al. Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia. N Engl J Med. 2016;374:311-22 pubmed publisher
    ..study of daily oral venetoclax in patients with relapsed or refractory CLL or small lymphocytic lymphoma (SLL) to assess safety, pharmacokinetic profile, and efficacy...
  72. Hasserjian R. Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Monoclonal B-Cell Lymphocytosis. Surg Pathol Clin. 2010;3:907-31 pubmed publisher
    Chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and monoclonal B-cell lymphocytosis (MBL) are clonal proliferations of small, mature B cells...
  73. Karatas F, Yalcin B, Sahin S, Akbulut H, Utkan G, Demirkazik A, et al. The significance of serum leptin level in patients with early stage nonsmall cell lung cancer. J Cancer Res Ther. 2017;13:204-207 pubmed publisher
    The serum leptin level (SLL) has been shown to increase in patients with nonsmall cell lung cancer (NSCLC)...
  74. Lam C, Curtis R, Dores G, Engels E, Caporaso N, Polliack A, et al. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma. J Clin Oncol. 2015;33:3096-104 pubmed publisher
    ..occurred among survivors of NHL, including 91 after chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and 111 after other NHL subtypes (cumulative incidence by age 85 years: CLL/SLL, 1.37%; other NHL subtypes, 0.78%)...
  75. Trew G, Pistofidis G, Brucker S, Kramer B, Ziegler N, Korell M, et al. A first-in-human, randomized, controlled, subject- and reviewer-blinded multicenter study of Actamax™ Adhesion Barrier. Arch Gynecol Obstet. 2017;295:383-395 pubmed publisher
    ..gynecologic laparoscopic abdominopelvic surgery with planned clinically indicated second-look laparoscopy (SLL) at 4-12 weeks...
  76. Szurián K, Csala I, Piurkó V, Deák L, Matolcsy A, Reiniger L. Quantitative miR analysis in chronic lymphocytic leukaemia/small lymphocytic lymphoma - proliferation centres are characterized by high miR-92a and miR-155 and low miR-150 expression. Leuk Res. 2017;58:39-42 pubmed publisher
    ..PCs) are histological hallmarks of lymph nodes in chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL)...
  77. Tooze J, Hamzic E, Willis F, Pettengell R. Differences between chronic lymphocytic leukaemia and small lymphocytic lymphoma cells by proteomic profiling and SNP microarray analysis. Cancer Genet. 2017;218-219:20-38 pubmed publisher
    ..cells in chronic lymphocytic leukaemia (CLL) circulate in the peripheral blood whereas small lymphocytic lymphoma (SLL) cells reside in tissues...
  78. Byers J, Qing X, Lo C, French S, Ji P. Unilateral localized conjunctival amyloidosis in a patient with a history of contralateral orbit/eyelid lymphoma. Exp Mol Pathol. 2018;104:151-154 pubmed publisher
    ..of anti-phospholipid antibody syndrome, Buerger's disease (thromboangitis obliterans), and small cell lymphoma (SLL) of the right orbit/eyelid...
  79. Kamiyama S, Ichimiya T, Ikehara Y, Takase T, Fujimoto I, Suda T, et al. Expression and the role of 3'-phosphoadenosine 5'-phosphosulfate transporters in human colorectal carcinoma. Glycobiology. 2011;21:235-46 pubmed publisher
    ..The relative amount of PAPST1 transcripts was found to be higher than those of PAPST2 in colorectal cancerous tissues...
  80. Safadi B, Shamseddine G, Elias E, Alami R. Definitive surgical management of staple line leak after sleeve gastrectomy. Surg Obes Relat Dis. 2015;11:1037-43 pubmed publisher
    ..The most serious complication is staple line leak (SLL), which is potentially life threatening and, in some patients, becomes chronic and difficult to manage...
  81. Coutre S, Furman R, Flinn I, Burger J, Blum K, Sharman J, et al. Extended Treatment with Single-Agent Ibrutinib at the 420 mg Dose Leads to Durable Responses in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Clin Cancer Res. 2017;23:1149-1155 pubmed publisher
    ..at doses of 420 and 840 mg in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) who were treatment-naïve (TN) or had relapsed/refractory (R/R) CLL after ≥1 prior therapy in a phase Ib/II ..
  82. Pratt K, Sigward S. Knee Loading Deficits During Dynamic Tasks in Individuals Following Anterior Cruciate Ligament Reconstruction. J Orthop Sports Phys Ther. 2017;47:411-419 pubmed publisher
    ..Participants performed 3 trials of overground running and a single-limb loading (SLL) task...
  83. Brown J, Hillmen P, O BRIEN S, Barrientos J, Reddy N, Coutre S, et al. Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL. Leukemia. 2017;: pubmed publisher
    ..Leukemia advance online publication, 21 July 2017; doi:10.1038/leu.2017.175...
  84. Ammann E, Shanafelt T, Larson M, Wright K, McDowell B, Link B, et al. Time to Second-line Treatment and Subsequent Relative Survival in Older Patients With Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Clin Lymphoma Myeloma Leuk. 2017;17:e11-e25 pubmed publisher
    ..excellent short-term outcomes in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma (CLL/SLL)...
  85. Matsumoto K, Hoshino M, Omori K, Igarashi H, Tsuruta T, Yamasaki K, et al. Compensatory mechanism of the spine after corrective surgery without lumbar-sacral fixation for traumatic thoracolumbar kyphotic spine deformity. J Orthop Sci. 2018;23:253-257 pubmed publisher
    ..altered by fracture (fTK), Pelvic Tilt (PT), Sacral Slope (SS), Pelvic Incidence (PI), Segmental Lumbar Lordosis (sLL: L3-S/L4-S), and local kyphotic angle were measured...
  86. Asadi Amoli F, Nozarian Z, Bonaki H, Mehrtash V, Entezari S. Clinicopathologic Assessment of Ocular Adnexal Lymphoproliferative Lesions at a Tertiary Eye Hospital in Iran. Asian Pac J Cancer Prev. 2016;17:3727-31 pubmed
    ..Patients with follicular lymphoma, large B-cell lymphoma or chronic lymphocytic leukemia/small cell lymphoma (CLL/SLL) tended to be older...
  87. Cotter J, Jamison S, Schloemer S, Chaudhari A. Do Neuromuscular Dentistry-Designed Mouthguards Enhance Dynamic Movement Ability in Competitive Athletes?. J Strength Cond Res. 2017;31:1627-1635 pubmed publisher
    ..the Functional Movement Screen (FMS), modified Star Excursion Balance Test (mSEBT), and a single-leg landing (SLL) task...
  88. Khade P, Devarakonda S. Coexisting multiple myeloma, lymphoma, and non-small cell lung cancer: a case report and review of the literature. Int Med Case Rep J. 2017;10:373-376 pubmed publisher
    ..Small lymphocytic lymphoma (SLL) is a neoplasm consisting of monoclonal B-cell lymphocyte proliferation...
  89. Kamiyama S, Suda T, Ueda R, Suzuki M, Okubo R, Kikuchi N, et al. Molecular cloning and identification of 3'-phosphoadenosine 5'-phosphosulfate transporter. J Biol Chem. 2003;278:25958-63 pubmed
    ..We have identified a novel human gene encoding a PAPS transporter, which we have named PAPST1, and the Drosophila melanogaster ortholog, slalom (sll)...
  90. Wang R, Yu G, He N, Wang Q, Zhao N, Xu Z, et al. Latitudinal variation of leaf stomatal traits from species to community level in forests: linkage with ecosystem productivity. Sci Rep. 2015;5:14454 pubmed publisher
    ..their linkage with net primary productivity (NPP), we investigated leaf stomatal density (SDL) and stomatal length (SLL) across 760 species from nine forest ecosystems in eastern China, and calculated the community-level SD (SDC) and ..
  91. Chang J, Havighurst T, Kim K, Eickhoff J, Traynor A, Kirby Slimp R, et al. Bendamustine + rituximab chemoimmunotherapy and maintenance lenalidomide in relapsed, refractory chronic lymphocytic leukaemia and small lymphocytic lymphoma: A Wisconsin Oncology Network Study. Br J Haematol. 2016;173:283-91 pubmed publisher
    ..response rates in relapsed/refractory (R/R) chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL). However, progression-free survival (PFS) after BR is <18 months...
  92. O Malley D, Lee J, Bellizzi A. Expression of LEF1 in mantle cell lymphoma. Ann Diagn Pathol. 2017;26:57-59 pubmed publisher
    Small lymphocytic lymphoma/chronic lymphocytic leukemia (CLL/SLL) and mantle cell lymphoma (MCL) usually are distinctly different in regard to clinical presentation, morphology, immunophenotype and molecular/genetic findings...